KalVista Pharmaceuticals

Money Moves

Target

For decades, people with hereditary angioedema had one option when an attack hit: inject themselves, often in a panic. In this genetic condition, the immune system misfires and swells tissues shut—sometimes fatally, closing the airway. In July 2025, a pill changed that.

Updated May 31